Axonics, Medtronic
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run afoul of three patents held by the company’s main rival, Medt | The case is one of several intellectual property disputes between the medtech giant and Axonics—which is currently waiting to become a subsidiary of Boston Scientific.
Jury says Axonics didn’t infringe on Medtronic patents
Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).
Jury sides with Axonics in Medtronic patent dispute
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California.
Axonics defeats Medtronic lawsuit in spine-stimulation patent trial
Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology.
Axonics gains after win in trial in patent dispute with Medtronic
Axonics Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as jury rules in its favor, awarding Medtronic nothing.
Zacks.com on MSN1mon
Medtronic (MDT) Progresses in CGM With New Approval, Alliance
Medtronic MDT recently announced two ... slim X2 became the first AID system to integrate with Abbott’s new FreeStyle Libre 2 Plus sensor. The breakthrough development enables t:slim X2 users ...
Hosted on MSN6mon
Medtronic's (MDT) MiniMed 780G System Study Data Favorable
New data was collected to assess how well ... The newest sensor is half the size of previous Medtronic sensors and features an improved user experience with a simple, two-step insertion ...
How Medtronic Makes Money
Learn the story of how Medtronic, one of the world's largest medical equipment and therapies suppliers, generates money and ...
medtechdive10d
Dexcom, Abbott OTC glucose sensors add to busy year for diabetes tech
New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.
MassDevice1d
Medtronic has a new VP, GM for TAVR, Congenital Heart
Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.
Azo Sensors10d
Advanced Materials for Sensing Applications: An Overview
Advanced materials are key to next-gen sensors, improving sensitivity and durability for critical applications in healthcare ...
DexCom: Investors Discounting Long CGM Growth Runway
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Medscape4d
Evaluating MRI-Compatible Pacemakers
New features, especially with regard to lead design and geometry, characterize the system. Specifically Medtronic redesigned ... of reed-switch to a Hall sensor. Furthermore, it has developed ...